TAKING PARTIAL PROFITS ON ULTA SALON, COSMETICS (ULTA)
We are taking partial profits on Ulta Salon (ULTA) right here at $53.31.
June 8, 2011
We are taking partial profits on Ulta Salon (ULTA) right here at $53.31.
Ciena (CIEN) reported terrible earnings. Further analysis of the earnings report shows that the optical market is deteriorating. Ciena is down over $3.00 in the premarket. At The Arora Report, we were expecting this down draft in Ciena as is evidenced by our past writings. Our
Acorda Therapeutics (ACOR) rumor spreaders are out in force. They are misleading the uninformed investors about a statement Biogen (BIIB) just made at a conference. We have taken partial profits on Acorda at $30.20. Our highest short tranche in Acorda is from $33.48. The rumor related to Biogen buying Acorda
Ulta Salon, Cosmetics (ULTA) runs health and beauty retail stores. This has been a fast growing chain. After the close Ulta Salon reported earnings of $0.37 per share $0.06 more than the consensus. Revenues rose 20.5% to $386 million vs $372 million. The Ulta Salon
Temple-Inland (TIN) bid by International Paper (IP) has antitrust risk. In some segments, the combined company will have over 30% market share. Such market share will invite scrutiny of Temple-Inland and International Paper by the Department of Justice. The possibility of the Department of Justice rejecting
This morning Talbots (TLB) reported lower than expected earnings. Projections from Talbots were also lower than expected. Talbots is going to close 100-200 stores. A proven way to make money is to buy when it is the darkest, but long-term fundamentals are in tact. Talbots
Those who did not take partial profits on Penson (PNSN) on Friday have now a second opportunity to take partial profits around $4.41. We will continue to hold the core position. Those not in the Penson may consider waiting for a deep pull back. We will provide
SunOpta (STKL) has run up on recommendation by Jim Cramer on CNBC. Based on the past trading pattern of SunOpta the run up in the range of $8.70 to $9.50 is an opportunity to sell. If there is an overall market correction, we will have an opportunity to
Our position Penson (PNSN) is rocketing this afternoon. Penson presented at Global Exchange Conference yesterday. There appears to be take over chatter. We are taking partial profits at $4.44.
Yesterday, we wrote that a number of education stocks are likely to see their multiples expand. Further analysis of the impact of new regulations show that Apollo (APOL) is the best positioned company to benefit from the new regulations. Apollo may run to mid $50’s. However,